Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults (Q59152686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

10 November 2019

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

3

M C Weinstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

6

K A Freedberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

B R Schackman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

S J Goldie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Zhang

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Public Health

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1456-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527782%20AND%20SRC:MED&resulttype=core&format=json

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

10 November 2019

cites work

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)

1 reference

12 December 2020

Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study

1 reference

12 December 2020

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Work Incentives Improvement Act

1 reference

12 December 2020

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001.

1 reference

12 December 2020

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

1 reference

12 December 2020

The lifetime cost of treating a person with HIV.

1 reference

12 December 2020

Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment.

1 reference

12 December 2020

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

12 December 2020

Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease

1 reference

12 December 2020

Insuring the poor through Section 1115 Medicaid waivers.

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

Medicaid eligibility policies for people with AIDS

1 reference

12 December 2020

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland

1 reference

12 December 2020

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

The cost-effectiveness of preventing AIDS-related opportunistic infections

1 reference

12 December 2020

Transitions in insurance and employment among people with HIV infection.

1 reference

12 December 2020

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

1 reference

12 December 2020

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

12 December 2020

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020